logo

For the Inventor, By the Inventor

Lodz, Poland

Andrzej Grajkowski

This inventor holds 4 USPTO granted patents. Top assignees: Polish Academy of Sciences, Polish Academy of Science. Active years: 1994-1999.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Andrzej Grajkowski. Retrieved from https://idiyas.com/inventor/andrzej-grajkowski-gtnklkky

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 4

% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 4

Forward Citations = 127(Granted Patents)


Company Filing History:

goldMedal3 out of 3 
 
Polish Academy of Sciences
 patents
silverMedal1 out of 1 
 
Polish Academy of Science
 patent

Years Active: 1994-1999

Loading Chart...
4 patents (USPTO):Explore Patents
1. 5883237 - Oligonucleotides having R.sub.p and S.sub.p linkages at predetermined (1999-03-16),
2. 5646267 - Method of making oligonucleotides and oligonucleotide analogs using (1997-07-08),
3. 5512668 - Solid phase oligonucleotide synthesis using phospholane intermediates (1996-04-30),
4. 5359052 - Chalcophospholanes useful in the synthesis of oligonucleoside (1994-10-25),

Title: **Inventor Andrzej Grajkowski: Contributions to Oligonucleotide Synthesis**

Introduction

Andrzej Grajkowski is a prominent inventor based in Lodz, Poland, recognized for his significant contributions to the field of oligonucleotide synthesis. With a total of four patents to his name, his innovative work has advanced the methodologies used in creating complex biomolecules.

Latest Patents

Grajkowski's recent patents focus on unique methods and compounds for the solid-phase synthesis of oligonucleotides and related polymers. One notable patent details oligonucleotides having R.sub.p and S.sub.p linkages, which are synthesized using protected monomer-O-[1,3,2-dichalcogen-substituted-phospholane] synthons in the presence of a catalytic base. The compounds developed through this invention include 2-N-substituted-1,3,2-dichalcogen-substituted-phospholane precursors and P-chiral oligonucleotides, highlighting the novelty and specificity of his research in oligonucleotide technology.

Career Highlights

Throughout his career, Grajkowski has been affiliated with esteemed institutions such as the Polish Academy of Sciences. His experience in research and development within such significant research institutions underlines his expertise and commitment to scientific advancement.

Collaborations

Grajkowski has collaborated with notable professionals in his field, including Bogdan Uznanski and Wojciech J. Stec. These partnerships have further enriched his research endeavors, showcasing the collaborative spirit prevalent in scientific exploration.

Conclusion

In conclusion, Andrzej Grajkowski's contributions to the field of oligonucleotides represent an important evolution in biochemistry and molecular biology. His patents reflect a deep understanding of complex chemical processes and a dedication to innovation, solidifying his stature as a significant figure in the world of inventors. As the science of synthesis continues to evolve, the impact of Grajkowski's work will undoubtedly influence future advancements in genetic research and medicine.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…